Home> Health Watch

Health Watch Archive

Less-invasive Brain Surgery Advantageous to Patients

November 30, 2011 Category :Health Watch 0

At the Loyola University Hospital in Chicago, incising a big portion of the human skull or face and likewise exposing a big area of the brain have been replaced by less-invasive brain surgery techniques.

» Continue Reading

Related terms:

, , ,

Protein Interactions may Cause Co-occuring Neurological Diseases

November 29, 2011 Category :Health Watch 0

A collaborative study investigated how neuronal proteins involved in neurodegenerative disorders, such as Parkinson’s and Alzheimer’s disease, interact and lead to the development of unique complexes. The study, which was performed by investigators from the Univeristy of California, San Diego and San Diego Supercomputer Center (SDSC).

» Continue Reading

Related terms:

, , ,

Excess Denture Cream Use may Lead to Nerve Damage

November 28, 2011 Category :Health Watch 0

Too much use of denture cream can lead to nerve damage, a recent study reveals. Researchers from the University of Texas Southwestern Medical Center in Dallas reported on four patients who habitually used “extremely large amounts”of dental cream and were found to develop neurological problems later on. All patients were found to have abnormally high zinc levels in their blood, along with abnormally low copper levels. Symptoms seen among patients included weakness in the hands, arms, and legs, poor balance, cognitive decline, and urinary incontinence.

» Continue Reading

Related terms:

, , ,

Diet as First-line Therapy for Infantile Spasms

November 27, 2011 Category :Health Watch 0

Traditionally used for intractable childhood epilepsy, the high fat, low carbohydrate ketogenic diet was found by a study to be an effective first-line treatment for spasms among four to eight-month old infants with epilepsy.

» Continue Reading

Related terms:

, , ,

FDA Approves Drug for Chorea Treatment in Huntington’s Disease

November 26, 2011 Category :Health Watch 0

Xenazine (tetrabenazine) has been approved by the United States Food and Drug Administration (US FDA) as the first drug for the treatment of chorea among patients with Huntington’s disease. “Xenazine represents hope for patients and families dealing with this difficult disease,” said Dr. Timothy Cote, director of FDA’s Office of Orphan Products Development. “For the first time, there is a treatment that can help patients with this disease gain some quality of life.”

» Continue Reading

Related terms:

, , , ,

New Approach to Detect Brain Tumor’s Treatment Response

November 25, 2011 Category :Health Watch 0

A certain kind of MRI scanning can now identify if brain tumors respond to treatment even before the onset of symptoms, according to a pilot study. Participated by researchers at Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center and Montreal Neurological Institute, the study was conducted among patients with recurring malignant tumors who were undergoing chemotherapy.

» Continue Reading

Related terms:

, , ,

Sleep Therapy: Low-Cost Treatment for Insomnia

November 24, 2011 Category :Health Watch 0

A neuroimaging study,”Prefontal Hypoactivation and Recovery in Insomnia,” has found that cognitive abnormalities caused by insomnia can be reversed through the non-pharmacologic approach of sleep therapy.

» Continue Reading

Related terms:

, ,